Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Publication Type
Facet Toggle
Article Type
Facet Toggle
Time Frame
Facet Toggle
Blog Post
June 14, 2024
Reuters reports today that the US Defense Department spread anti-vaccine messaging across Southeast Asia during COVID as part of an effort to discredit Chinese-manufactured vaccines. At a minimum, the Administration should amend EO 12333 to mandate that no US intelligence or psychological warfare op...
Blog Post
November 15, 2023
One of the most salient lessons from the pandemic is the need to diversify manufacturing capabilities and bolster supply resilience to avoid a repeat of the slow and inequitable vaccine roll out in African countries. To turn this lesson into action, the Gavi Secretariat is rapidly advancing plans fo...
Blog Post
September 21, 2023
The politics of antimicrobial resistance (AMR) has changed substantially since we launched the first CGD working group on AMR in 2007. There is now much more awareness about the need to act, even if global solutions have not yet been implemented. Countries including the UK, Canada, and Japan have an...
REPORTS
September 20, 2023
In our final working group report, we outline the principles of a Grand Bargain that we believe all stakeholders can and should sign up to during the UN General Assembly's High-Level Meeting on antimicrobial resistance in 2024. Explore our recommendations on increasing the availability of critically...
Blog Post
August 03, 2023
On August 1, 2023, the US Secretary of State Antony Blinken launched the new Bureau of Global Health Security and Diplomacy at the Acheson Auditorium in the State Department. Reorganizing government is unglamorous and rife with political hazards, but it has the potential to build a faster and better...
May
18
2023
10:00—11:00 AM ET / 3:00-4:00 PM BST
May 08, 2023
Swift and effective responses to disease outbreaks require a versatile toolkit. Pooled procurement can play a key role in enabling rapid access to safe, effective, and affordable medical countermeasures like vaccines and therapeutics. This procurement arrangement is associated with benefits such as ...
Blog Post
April 24, 2023
Despite the vivid challenges of the early phase of the COVID-19 pandemic, the world remains unprepared to manufacture and distribute vaccines for the next large health emergency or pandemic. Although the global response to COVID-19 has seen major advances in vaccine technology and distribution, it h...
Nov
14
2022
VIRTUAL
8:30—12:00 PM Eastern Time (US & Canada)/ 1:30—5:00pm Greenwich Mean Time (GMT)
October 28, 2022
Climate change, conflict, food insecurity, and pandemics. These global challenges are growing in urgency, and complexity—and they are not confined by borders. While wealthy countries are aging and their growth rates are faltering, the traditional manufacturing-led path to rapid growth in poorer coun...